CTM01 is a murine-derived IgG1 (or humanized IgG4) monoclonal antibody inhibitor targeting MUC1. It exhibits broad-spectrum anticancer activity against epithelial-derived solid tumors such as breast cancer, lung cancer, and ovarian cancer.
Target-Kategorie:
Mucin
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten